ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3247

Dietary Intake of Omega-3 Fatty Acids and Vitamin C and D Associate with Decreased Pain, Independent of Inflammation, in MTX Treated Early RA Patients

Cecilia Lourdudoss1, Alicja Wolk2, Lars Alfredsson3, Lars Klareskog4, Ronald F. van Vollenhoven5 and Jon Lampa6, 1Dept. of Medicine, ClinTRID, Karolinska institutet, Stockholm, Sweden, 2Institute of Environmental Medicine (IMM), Karolinska institutet, Stockholm, Sweden, 3The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, 4Department of Medicine, Karolinska University Hospital, Stockholm, Sweden, 5Department of Medicine, Unit for Clinical Therapy Research, Inflammatory Diseases (ClinTRID), The Karolinska Institute, Stockholm, Sweden, 6Dep of Medicine, Rheumatology unit, Karolinska Institute, Karolinska Institute, Stockholm, Sweden

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: methotrexate (MTX), nutrition, pain and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Wednesday, November 11, 2015

Title: Pain: Clinical Aspects

Session Type: ACR Concurrent Abstract Session

Session Time: 11:00AM-12:30PM

Background/Purpose:

Chronic pain is common in RA and considered as the major disease burden from the patients’ perspective. Earlier data suggest that omega-3 fatty acids, vitamin D and vitamin C are anti-inflammatory and can decrease disease activity in RA. Also, excessive intake of omega-6 fatty acids has been linked with inflammation. However, little is known how these dietary factors may affect pain in RA. Our aim was to study the association between diet and pain, in spite of inflammation, after three months of MTX treatment in early RA patients.

Methods:

We included newly diagnosed RA patients with MTX monotherapy from Epidemiological Investigation of Rheumatoid Arthritis (EIRA) linked to clinical data in the Swedish Rheumatology Quality register (SRQ). Dietary data based on food frequency questionnaires were linked with data on pain after three months of MTX treatment. Pain in spite of inflammatory control (remaining pain) was defined based on the patient acceptance of symptoms scale (PASS) (1) together with low systemic inflammation (VAS>40 + CRP<10) at the three months follow-up. Associations between dietary nutrient intake and remaining pain were analyzed with logistic regression, adjusted for age, sex and BMI.

Results:

This study included 628 RA patients. 70.1% were females and the median age was 55 years. 68.0% were ACPA positive. Mean values for clinical measures: DAS28 5.1, VAS pain 53.8 and HAQ 1.0. All patients received MTX monotherapy and the mean BMI was 25.8 kg/m2.

After three months of MTX treatment, 103 patients (16.4%) had remaining pain. Higher intake of omega-3, vitamin D and vitamin C were inversely associated with remaining pain (OR=0.4[95% CI: 0.2-0.7], OR=0.5[95% CI: 0.3-0.8] and OR=0.5[95% CI: 0.3-0.9], respectively), whereas a higher omega-6:3 ratio was associated with increased risk of remaining pain (OR=2.7[95% CI: 1.6-4.7]). Adjustment for ACPA status did not change the ORs markedly.

Conclusion:

Intake of anti-inflammatory fatty acids and antioxidants are known to affect disease activity, and here we show that also pain may be affected, regardless of inflammation. Our findings reflect an inverse association between increased intake of omega-3, vitamin D and vitamin C, respectively and remaining pain. In addition, higher omega-6:3 ratio was found to associate with increased pain. These effects were independent of inflammation. Altogether, our data indicate that omega-3, vitamin D and vitamin C may dampen the development of chronic pain in early RA.

Reference:

1. Tubach F et al, Arthritis Care Res (Hoboken). 2012;64(11):1699-707.


Disclosure: C. Lourdudoss, None; A. Wolk, None; L. Alfredsson, None; L. Klareskog, None; R. F. van Vollenhoven, None; J. Lampa, None.

To cite this abstract in AMA style:

Lourdudoss C, Wolk A, Alfredsson L, Klareskog L, van Vollenhoven RF, Lampa J. Dietary Intake of Omega-3 Fatty Acids and Vitamin C and D Associate with Decreased Pain, Independent of Inflammation, in MTX Treated Early RA Patients [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/dietary-intake-of-omega-3-fatty-acids-and-vitamin-c-and-d-associate-with-decreased-pain-independent-of-inflammation-in-mtx-treated-early-ra-patients/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dietary-intake-of-omega-3-fatty-acids-and-vitamin-c-and-d-associate-with-decreased-pain-independent-of-inflammation-in-mtx-treated-early-ra-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology